U.S. Marine and Shipping Stock News

New 25% U.S. tariffs on a wide range of Brazilian imports are reshaping trade routes, freight demand, and where goods enter key consumer markets. For global logistics and freight forwarding stocks, this kind of disruption can shift volumes, pricing power, and customer mix in ways that matter for portfolios. This article looks at three stocks from a Global Logistics and Freight Forwarding Companies screener that appear exposed to the latest tariff headlines in potentially positive ways, and...

Viking Therapeutics (VKTX) recently launched a Phase 1 single ascending dose study of VK3019, a Dual Amylin and Calcitonin Receptor Agonist being tested as a potential weight loss therapy in adults with obesity. See our latest analysis for Viking Therapeutics. The VK3019 update comes as Viking Therapeutics shares trade at $36.37, with the stock down 11.59% over the past week but up 22.66% on a 30 day share price return and supported by a very large 5 year total shareholder return of more than...

Why this leadership shake up at MBX Biosciences matters for investors MBX Biosciences (MBX) is in focus after the board promoted Executive Chairman Steve Hoerter to Chief Executive Officer and Chairman, while confirming John Smither as Chief Financial Officer, reshaping the company’s senior leadership team. See our latest analysis for MBX Biosciences. The leadership changes at MBX Biosciences arrive after a sharp run up in momentum, with the stock showing a 45.47% 1 month share price return...

Earlier this week, Power Integrations announced ultra-slim 15 W and 35 W auxiliary power supply reference designs tailored to NVIDIA’s Kyber 800 VDC AI data center architecture, using its InnoMux-2 ICs to cut board space and bill of materials by about 30 percent while maintaining at least 88 percent efficiency. By offering a compact alternative to bulkier silicon carbide-based designs for internal data center components, the company is aiming to embed its technology deeper into...

Enovis Corporation recently launched CT-RevitL in the U.S., a next-generation veterinary PBM laser therapy system from its Companion Animal Health business, designed to improve clinical performance, mobility and ease of use for veterinary teams. The system’s COMPASS technology, which guides precise, calibrated dosing and aims to standardize laser therapy delivery, could make advanced non-drug pain management more accessible and repeatable across everyday veterinary practice workflows. Next,...

United Therapeutics stock has delivered a strong 5 year run, yet its current valuation checks still lean toward the shares looking inexpensive rather than stretched, even as recent insider selling and fresh clinical and regulatory news give investors more to weigh. United Therapeutics has returned 184.8% over the past 5 years, which puts extra focus on whether the current share price still reflects a reasonable entry point after such a long period of gains. Recent FDA approval for the LungFX...

John Wiley & Sons (WLY) has drawn fresh attention after appointing Frank Scognamiglio as Corporate Vice President and Chief Accounting Officer, while former CAO Christopher Caridi has shifted to a Senior Vice President, Business Transformation role. See our latest analysis for John Wiley & Sons. At a share price of $50.94, John Wiley & Sons has seen strong recent momentum, with a 30 day share price return of 12.97% and a year to date share price return of 72.68%, while the 3 year total...

Del Monte stock has delivered a 22.5% gain over the past three years, yet its valuation signals are split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to a premium to the current fundamentals while market multiples suggest the shares may still be priced below what the earnings profile implies. Over the last three years, Del Monte has returned 22.5%, which puts recent share price swings in the context of a longer period of steady, but not spectacular, gains. Recent...

Baidu announces a reported AI partnership with Apple focused on integrating its generative AI capabilities. The company also confirms a voluntary move to a dual-primary listing on the Hong Kong Stock Exchange. Both developments come as Baidu's NasdaqGS:BIDU shares last closed at $112.82. Baidu is back in focus after it reported a new AI partnership with Apple and outlined plans to convert to a dual-primary listing in Hong Kong. The stock, NasdaqGS:BIDU, has fallen 24.9% year to date but is...

Tech headlines have been busy, from Netflix and Alphabet share moves to questions around election betting and even pressure on private market giants like SpaceX. Sharp reactions such as an 8% drop in Netflix or a 4% slide in Alphabet can push investors to reassess what they are really paying for growth, cash flow and balance sheet strength. This article looks at three technology stocks from a value focused screener that appear especially exposed to these news catalysts. It outlines how each...

Stubborn import price pressure and talk of higher for longer rates are putting U.S. industrial and technology equipment stocks under a sharper spotlight, especially those tied to machinery, computers, and semiconductors. With Chinese import costs climbing and AI related hardware getting more expensive, some companies could see margins squeezed while others may find room to improve pricing power. This article explains how the latest data may affect a selection of large equipment manufacturers...

Booz Allen Hamilton Holding (BAH) recently reported fourth quarter fiscal 2026 adjusted earnings per share of $1.78, above the consensus estimate of $1.32, with earnings up 10.6% year over year. See our latest analysis for Booz Allen Hamilton Holding. Despite the earnings beat, Booz Allen Hamilton Holding’s recent share price return shows pressure, with the 30 day share price return down 11.8% and the year to date share price return down 23.1%. The 1 year total shareholder return is down...

On 7 July 2026, Apollo Commercial Real Estate Finance, Inc. (NYSE: ARI) was removed from both the S&P TMI Index and the S&P Global BMI Index, reducing its presence in widely followed equity benchmarks. This dual index removal matters because it can alter how index-tracking funds and benchmark-aware investors engage with ARI, potentially affecting trading patterns and liquidity. Next, we’ll examine how ARI’s removal from key S&P indices might influence its existing investment narrative and...

Trevi Therapeutics stock has delivered a very large 5 year return, yet the current valuation checks lean expensive rather than cheap, which raises the question of how much of that strength is already reflected in the price. Over the past 5 years, Trevi Therapeutics has returned about 7.6x, which sets a high bar for any further upside to be justified by fundamentals. Future progress in turning its drug pipeline into consistent revenue can support the current share price. The risk is that...

Millicom International Cellular stock has delivered very strong returns over recent years, and the current valuation checks still suggest the shares screen as cheap on several measures. This raises the question of how much of that strength is already reflected in the price. Over the last 3 years, Millicom International Cellular has delivered a very large total return, which puts extra focus on whether recent gains are supported by fundamentals. For the business, expectations around...

Marriott Vacations Worldwide (VAC) has drawn fresh attention after recent trading, with the stock last closing at $101.83. Short term returns remain positive, while longer multi year performance has been more mixed for shareholders. See our latest analysis for Marriott Vacations Worldwide. The recent 2.22% 1 day share price return at $101.83 extends a strong run, with a 73.03% year to date share price return contrasting with weaker multi year total shareholder returns, which remain down over...

Fortinet (FTNT) stock is back in focus after the company expanded its FortiEndpoint platform with new AI focused security tools and named TD SYNNEX an approved global distributor for multi region cybersecurity deployments. See our latest analysis for Fortinet. That backdrop of AI focused product updates and the new TD SYNNEX distribution agreement comes after a strong run in Fortinet shares, with a 30 day share price return of 9.36%, a 90 day share price return of 96.46% and a 1 year total...

Regeneron Pharmaceuticals has delivered a 24.1% return over the past year, yet the stock still screens as undervalued on broad valuation checks. This raises the question of whether the market is fully pricing in its recent progress and setbacks. A 24.1% one year return suggests sentiment toward Regeneron Pharmaceuticals has been constructive, even with shorter term pullbacks earlier in the year. Regulatory momentum around dupilumab and other key products can support higher earnings...

Fox stock has posted a strong 74.7% return over the past three years, yet current valuation work suggests the market price may still sit well below an estimate of intrinsic value based on a Discounted Cash Flow (DCF) approach and traditional earnings multiples. With recent headlines around the proposed Roku acquisition and shifting sports rights economics, investors are weighing whether that apparent discount fairly reflects the risks now attached to the story. Fox's 74.7% return over three...

Emerson Electric (NYSE:EMR) introduced new refinery automation solutions that integrate crude scheduling and product blending into its Aspen Unified Scheduling platform. The launch targets margin critical refinery workflows, aiming to reduce manual interventions and support faster responses to market volatility. Emerson Electric, trading at $139.08, is adding another software layer around its automation hardware with this refinery focused rollout. The stock is up 59.9% over the past 3 years...

In the last week, the United States market has stayed flat, yet it has risen by 19% over the past year with earnings forecasted to grow by 18% annually. In such a climate, identifying stocks that are potentially undervalued can be an effective strategy for investors seeking opportunities that may offer significant upside relative to their intrinsic value.

Over the last 7 days, the United States market has remained flat, yet it has shown impressive growth of 19% over the past year with earnings expected to increase by 18% annually. In this environment, identifying growth companies with significant insider ownership can be particularly appealing as it often signals confidence in a company's potential and alignment of interests between management and shareholders.

The United States market remained flat over the last week, but it is up 19% over the past year, with earnings forecast to grow by 18% annually. The term 'penny stocks' might feel like a relic of past market eras, but the potential they represent is as real as ever. Typically referring to smaller or relatively new companies, these stocks can provide a mix of affordability and growth potential when paired with strong financials.

In July 2026, GRAIL announced it had expanded its collaboration with Priority Health, enabling Michigan self-insured employer groups to add the Galleri multi-cancer early detection blood test to their existing cancer screening coverage. This move broadens access to an MCED test backed by large-scale clinical evidence, potentially influencing how employers and health plans approach early cancer detection benefits. Next, we’ll examine how Priority Health’s employer-group access to Galleri...